These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3149503)

  • 1. Proteolytic modification of tissue plasminogen activator: importance of the N-terminal part of the catalytically active B-chain for enzymatic activity.
    Norrman B; Ohlsson PI; Wallén P
    Biochemistry; 1988 Nov; 27(22):8325-30. PubMed ID: 3149503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytically induced variations in the enzymatic properties of tissue plasminogen activator. Activations, inactivations and reactivations.
    Norrman B; Pohl G; Jörnvall H; Wallén P
    Eur J Biochem; 1986 Aug; 159(1):7-13. PubMed ID: 2943592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain.
    Burck PJ; Berg DH; Warrick MW; Berg DT; Walls JD; Jaskunas SR; Crisel RM; Weigel B; Vlahos CJ; McClure DB
    J Biol Chem; 1990 Mar; 265(9):5170-7. PubMed ID: 2108167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The single-chain form of tissue-type plasminogen activator has catalytic activity: studies with a mutant enzyme that lacks the cleavage site.
    Boose JA; Kuismanen E; Gerard R; Sambrook J; Gething MJ
    Biochemistry; 1989 Jan; 28(2):635-43. PubMed ID: 2496749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416.
    Petersen LC; Boel E; Johannessen M; Foster D
    Biochemistry; 1990 Apr; 29(14):3451-7. PubMed ID: 2112946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE; Will H
    Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Erythrina protease inhibitor: interactions with tissue plasminogen activator.
    Heussen-Schemmer C; Merrifield EH; Dowdle EB
    Thromb Haemost; 1991 Aug; 66(2):226-31. PubMed ID: 1771616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis.
    Tate KM; Higgins DL; Holmes WE; Winkler ME; Heyneker HL; Vehar GA
    Biochemistry; 1987 Jan; 26(2):338-43. PubMed ID: 3103680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.
    Lindahl TL; Ohlsson PI; Wiman B
    Biochem J; 1990 Jan; 265(1):109-13. PubMed ID: 2105714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity.
    Fischer B; Zacharias U; Will H
    Biol Chem Hoppe Seyler; 1991 Apr; 372(4):263-71. PubMed ID: 1905550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.
    Dodd I; Fears R; Robinson JH
    Thromb Haemost; 1986 Feb; 55(1):94-7. PubMed ID: 3085269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity of tissue type plasminogen activator. Characterization of the fibrin independent specificity of t-PA for plasminogen.
    Madison EL; Coombs GS; Corey DR
    J Biol Chem; 1995 Mar; 270(13):7558-62. PubMed ID: 7706303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
    Robbins KC; Boreisha IG
    Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue-type plasminogen activator.
    Okada K; Ueshima S; Matsuno H; Nagai N; Kawao N; Tanaka M; Matsuo O
    J Thromb Haemost; 2011 May; 9(5):997-1006. PubMed ID: 21392255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysteretic behaviour of citrate synthase. Site-directed limited proteolysis.
    Lill U; Schreil A; Henschen A; Eggerer H
    Eur J Biochem; 1984 Aug; 143(1):205-12. PubMed ID: 6381053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the three-dimensional structure of the enzymatic domain of t-PA.
    Heckel A; Hasselbach KM
    J Comput Aided Mol Des; 1988 Apr; 2(1):7-14. PubMed ID: 3143811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function.
    Bode W; Renatus M
    Curr Opin Struct Biol; 1997 Dec; 7(6):865-72. PubMed ID: 9434908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage.
    Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E
    Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C; Veerman H; Blasi F; Pannekoek H
    Biochemistry; 1988 Apr; 27(7):2565-72. PubMed ID: 3132969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.